Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate vs Carbamazepine in Benign Rolandic Epilepsy
NCT00216567Phase 4Completed
- Sponsor
- Janssen Pharmaceutical
- Start
- Dec 2002
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of topiramate in Benign Rolandic Epilepsy (BECTS), sponsored by Janssen Pharmaceutical. Started Dec 2002; status: completed.
02
Drugs
topiramate
03
Conditions
Benign Rolandic Epilepsy (BECTS)
Beyond the preview
Go deeper on NCT00216567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00216567.